{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:33:07Z","timestamp":1772649187511,"version":"3.50.1"},"reference-count":122,"publisher":"Elsevier","isbn-type":[{"value":"9780443194047","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.vh.2024.03.001","type":"book-chapter","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T13:54:36Z","timestamp":1712930076000},"page":"191-217","source":"Crossref","is-referenced-by-count":2,"title":["Gene therapy targeting the blood-brain barrier"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.vh.2024.03.001_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-61779-370-7_3","article-title":"AAV capsid structure and cell interactions","volume":"807","author":"Agbandje-McKenna","year":"2011","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/bs.vh.2024.03.001_bib2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.149.3685.754","article-title":"Adenovirus-associated defective virus particles","volume":"149","author":"Atchison","year":"1965","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.vh.2024.03.001_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal2379","article-title":"Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology","volume":"357","author":"Augustin","year":"2017","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.vh.2024.03.001_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/hum.2019.186","article-title":"Ly6a differential expression in blood-brain barrier is responsible for strain specific central nervous system transduction profile of AAV-PHP.B","volume":"31","author":"Batista","year":"2020","journal-title":"Human Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4939-9092-4_8","article-title":"Lipids for nucleic acid delivery: Cationic or neutral lipoplexes, synthesis, and particle formation","volume":"1943","author":"Bessodes","year":"2019","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/bs.vh.2024.03.001_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf4888","article-title":"BBB opening with focused ultrasound in nonhuman primates and Parkinson\u2019s disease patients: Targeted AAV vector delivery and PET imaging","volume":"9","author":"Blesa","year":"2023","journal-title":"Science Advances"},{"key":"10.1016\/bs.vh.2024.03.001_bib7","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","article-title":"A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine","volume":"92","author":"Boussif","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2024.03.001_bib8","series-title":"The genus dependovirus. In parvoviruses","first-page":"15","author":"Bowles","year":"2006"},{"key":"10.1016\/bs.vh.2024.03.001_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/exnr.1996.0178","article-title":"Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor","volume":"142","author":"Broadwell","year":"1996","journal-title":"Experimental Neurology"},{"key":"10.1016\/bs.vh.2024.03.001_bib10","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s00018-017-2501-5","article-title":"Transfection of primary brain capillary endothelial cells for protein synthesis and secretion of recombinant erythropoietin: A strategy to enable protein delivery to the brain","volume":"74","author":"Burkhart","year":"2017","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/bs.vh.2024.03.001_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-015-0015-9","article-title":"Transfection of brain capillary endothelial cells in primary culture with defined blood\u2013brain barrier properties","volume":"12","author":"Burkhart","year":"2015","journal-title":"Fluids and Barriers of the CNS"},{"key":"10.1016\/bs.vh.2024.03.001_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/595830","article-title":"Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses","volume":"199","author":"Calcedo","year":"2009","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/bs.vh.2024.03.001_bib13","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nature Neuroscience"},{"key":"10.1016\/bs.vh.2024.03.001_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.virol.2007.02.018","article-title":"Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A","volume":"364","author":"Chapagain","year":"2007","journal-title":"Virology"},{"key":"10.1016\/bs.vh.2024.03.001_bib15","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1038\/s41467-023-38582-7","article-title":"Functional gene delivery to and across brain vasculature of systemic AAVs with endothelial-specific tropism in rodents and broad tropism in primates","volume":"14","author":"Chen","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/bs.vh.2024.03.001_bib16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.2025","article-title":"Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy","volume":"15","author":"Chen","year":"2009","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.vh.2024.03.001_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nbt.3440","article-title":"Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain","volume":"34","author":"Deverman","year":"2016","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.vh.2024.03.001_bib18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.molmed.2020.09.010","article-title":"Journey to the center of the cell: Tracing the path of AAV transduction","volume":"27","author":"Dhungel","year":"2021","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/bs.vh.2024.03.001_bib19","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1177\/0271678X19865917","article-title":"Brain endothelial specific gene therapy improves experimental Sandhoff disease","volume":"40","author":"Dogbevia","year":"2020","journal-title":"Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/bs.vh.2024.03.001_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.24981","article-title":"Gene therapy decreases seizures in a model of Incontinentia pigmenti","volume":"82","author":"Dogbevia","year":"2017","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.vh.2024.03.001_bib21","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2217\/fvl.13.112","article-title":"Adeno-associated virus structural biology as a tool in vector development","volume":"8","author":"Drouin","year":"2013","journal-title":"Future Virology"},{"key":"10.1016\/bs.vh.2024.03.001_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/hum.2019.274","article-title":"Adeno-associated virus serotype-specific inverted terminal repeat sequence role in vector transgene expression","volume":"31","author":"Earley","year":"2020","journal-title":"Human Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.omtm.2019.09.003","article-title":"Nanobody-enhanced targeting of AAV gene therapy vectors","volume":"15","author":"Eichhoff","year":"2019","journal-title":"Molecular Therapy Methods & Clinical Development"},{"key":"10.1016\/bs.vh.2024.03.001_bib24","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1038\/s41467-021-26485-4","article-title":"The membrane associated accessory protein is an adeno-associated viral egress factor","volume":"12","author":"Elmore","year":"2021","journal-title":"Nature Communications"},{"key":"10.1016\/bs.vh.2024.03.001_bib25","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1172\/JCI118306","article-title":"Brain endothelial cell infection in children with acute fatal measles","volume":"96","author":"Esolen","year":"1995","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.vh.2024.03.001_bib26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/j.gastro.2011.11.028","article-title":"Hepatitis C virus infects the endothelial cells of the blood-brain barrier","volume":"142","author":"Fletcher","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.vh.2024.03.001_bib27","article-title":"AAV engineering for improving tropism to the central nervous system","volume":"12","author":"Ghauri","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1016\/bs.vh.2024.03.001_bib28","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/12491","article-title":"Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2","volume":"5","author":"Girod","year":"1999","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.vh.2024.03.001_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41593-021-00969-4","article-title":"AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset","volume":"25","author":"Goertsen","year":"2022","journal-title":"Nature Neuroscience"},{"key":"10.1016\/bs.vh.2024.03.001_bib30","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1089\/hum.2016.109","article-title":"Direct intracranial injection of AAVrh8 encoding monkey beta-N-acetylhexosaminidase causes neurotoxicity in the primate brain","volume":"28","author":"Golebiowski","year":"2017","journal-title":"Human Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib31","doi-asserted-by":"crossref","first-page":"9398","DOI":"10.1128\/JVI.00954-09","article-title":"Mouse adenovirus type 1-induced breakdown of the blood-brain barrier","volume":"83","author":"Gralinski","year":"2009","journal-title":"Journal of Virology"},{"key":"10.1016\/bs.vh.2024.03.001_bib32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0271678X211039617","article-title":"Short regulatory DNA sequences to target brain endothelial cells for gene therapy","volume":"42","author":"Grasshoff","year":"2022","journal-title":"Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/bs.vh.2024.03.001_bib33","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1128\/JVI.00254-08","article-title":"In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses","volume":"82","author":"Grimm","year":"2008","journal-title":"Journal of Virology"},{"key":"10.1016\/bs.vh.2024.03.001_bib34","doi-asserted-by":"crossref","first-page":"bnz008","DOI":"10.1210\/endrev\/bnz008","article-title":"Thyroid hormone transporters","volume":"41","author":"Groeneweg","year":"2020","journal-title":"Endocrine Reviews"},{"key":"10.1016\/bs.vh.2024.03.001_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.857276","article-title":"Overcoming the challenges imposed by humoral immunity to AAV vectors to achieve safe and efficient gene transfer in seropositive patients","volume":"13","author":"Gross","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.vh.2024.03.001_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.08.021","article-title":"High-titer AAV disrupts cerebrovascular integrity and induces lymphocyte infiltration in adult mouse brain","author":"Guo","year":"2023","journal-title":"Molecular Therapy\u2014Methods & Clinical Development"},{"key":"10.1016\/bs.vh.2024.03.001_bib37","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1073\/pnas.1720032115","article-title":"Flavivirus internalization is regulated by a size-dependent endocytic pathway","volume":"115","author":"Hackett","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2024.03.001_bib38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/jnc.14982","article-title":"Gene therapy to the blood\u2013brain barrier with resulting protein secretion as a strategy for treatment of Niemann Picks type C2 disease","volume":"156","author":"Hede","year":"2021","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.vh.2024.03.001_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102712","article-title":"Vascular endothelial cells: Heterogeneity and targeting approaches","volume":"10","author":"Hennigs","year":"2021","journal-title":"Cells"},{"key":"10.1016\/bs.vh.2024.03.001_bib40","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1073\/pnas.81.20.6466","article-title":"Use of adeno-associated virus as a mammalian DNA cloning vector: Transduction of neomycin resistance into mammalian tissue culture cells","volume":"81","author":"Hermonat","year":"1984","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2024.03.001_bib41","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ymthe.2019.02.013","article-title":"The GPI-linked protein LY6A drives AAV-PHP.B transport across the blood-brain barrier","volume":"27","author":"Hordeaux","year":"2019","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225206","article-title":"Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids","volume":"14","author":"Huang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/bs.vh.2024.03.001_bib43","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/10611860903105986","article-title":"Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries","volume":"17","author":"H\u00fclsermann","year":"2009","journal-title":"Journal of Drug Targeting"},{"key":"10.1016\/bs.vh.2024.03.001_bib44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","article-title":"Transferrin receptor on endothelium of brain capillaries","volume":"312","author":"Jefferies","year":"1984","journal-title":"Nature"},{"key":"10.1016\/bs.vh.2024.03.001_bib45","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1089\/104303403322168019","article-title":"In vivo delivery of glial cell-derived neurotrophic factor across the blood-brain barrier by gene transfer into brain capillary endothelial cells","volume":"14","author":"Jiang","year":"2003","journal-title":"Human Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70290-w","article-title":"Plasmid DNA gene therapy of the Niemann-Pick C1 mouse with transferrin receptor-targeted Trojan horse liposomes","volume":"10","author":"Jiang","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.vh.2024.03.001_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11220-1","article-title":"Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma","volume":"7","author":"Johnsen","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.vh.2024.03.001_bib48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.omtm.2023.02.016","article-title":"A blood-brain barrier-penetrating AAV2 mutant created by a brain microvasculature endothelial cell-targeted AAV2 variant","volume":"29","author":"Kawabata","year":"2023","journal-title":"Molecular Therapy Methods & Clinical Development"},{"key":"10.1016\/bs.vh.2024.03.001_bib49","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1016\/j.biomaterials.2009.08.049","article-title":"Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer","volume":"30","author":"Ke","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/bs.vh.2024.03.001_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2015.47","article-title":"Super-resolution imaging of nuclear import of adeno-associated virus in live cells","volume":"2","author":"Kelich","year":"2015","journal-title":"Molecular Therapy Methods & Clinical Development"},{"key":"10.1016\/bs.vh.2024.03.001_bib51","doi-asserted-by":"crossref","first-page":"11072","DOI":"10.1128\/JVI.77.20.11072-11081.2003","article-title":"Identification of a heparin-binding motif on adeno-associated virus type 2 capsids","volume":"77","author":"Kern","year":"2003","journal-title":"Journal of Virology"},{"key":"10.1016\/bs.vh.2024.03.001_bib52","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/hum.2021.287","article-title":"Global seroprevalence of pre-existing immunity against AAV5 and other AAV serotypes in people with hemophilia A","volume":"33","author":"Klamroth","year":"2022","journal-title":"Human Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib53","doi-asserted-by":"crossref","first-page":"609","DOI":"10.15252\/emmm.201506078","article-title":"A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases","volume":"8","author":"Korbelin","year":"2016","journal-title":"EMBO Molecular Medicine"},{"key":"10.1016\/bs.vh.2024.03.001_bib54","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1073\/pnas.87.6.2211","article-title":"Site-specific integration by adeno-associated virus","volume":"87","author":"Kotin","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2024.03.001_bib55","first-page":"389","article-title":"A high-efficiency AAV for endothelial cell transduction throughout the central nervous system","volume":"1","author":"Krolak","year":"2022","journal-title":"Nature\u00a0Cardiovascular Research"},{"key":"10.1016\/bs.vh.2024.03.001_bib56","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/s41467-018-04529-6","article-title":"Blood-brain barrier opening in Alzheimer\u2019s disease using MR-guided focused ultrasound","volume":"9","author":"Lipsman","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/bs.vh.2024.03.001_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11011-020-00630-2","article-title":"Crossing the blood-brain barrier with AAV vectors","volume":"36","author":"Liu","year":"2021","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/bs.vh.2024.03.001_bib58","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","article-title":"Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles","volume":"30","author":"Liu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/bs.vh.2024.03.001_bib59","article-title":"In vivo editing of the pan-endothelium by immunity evading simian adenoviral vector","volume":"158","author":"Lorincz","year":"2022","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/bs.vh.2024.03.001_bib60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40246-016-0074-2","article-title":"Organization, evolution and functions of the human and mouse Ly6\/uPAR family genes","volume":"10","author":"Loughner","year":"2016","journal-title":"Human Genomics"},{"key":"10.1016\/bs.vh.2024.03.001_bib61","first-page":"19","article-title":"Virus structure and classification","author":"Louten","year":"2016","journal-title":"Essential Human Virology"},{"key":"10.1016\/bs.vh.2024.03.001_bib62","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/acsabm.8b00502","article-title":"Synthetic polymer nanoparticles functionalized with different ligands for receptor-mediated transcytosis across blood-brain barrier","volume":"1","author":"Lu","year":"2018","journal-title":"ACS Applied Bio Materials"},{"key":"10.1016\/bs.vh.2024.03.001_bib63","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJMoa2211075","article-title":"Two-year outcomes of valoctocogene roxaparvovec therapy for hemophilia A","volume":"388","author":"Mahlangu","year":"2023","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.vh.2024.03.001_bib64","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1160\/TH09-05-0310","article-title":"Organ- and endotheliotropism of Nipah virus infections in vivo and in vitro","volume":"102","author":"Maisner","year":"2009","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/bs.vh.2024.03.001_bib65","article-title":"Coxsackievirus B3 infects and disrupts human induced-pluripotent stem cell derived brain-like endothelial cells","volume":"13","author":"Mamana","year":"2023","journal-title":"Frontiers in\u00a0Cellular\u00a0and\u00a0Infection Microbiology"},{"key":"10.1016\/bs.vh.2024.03.001_bib66","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/mt.2009.15","article-title":"AAV9: A potential blood-brain barrier buster","volume":"17","author":"Manfredsson","year":"2009","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib67","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1038\/s41467-018-06000-y","article-title":"LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step","volume":"9","author":"Mar","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/bs.vh.2024.03.001_bib68","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ejmg.2012.04.007","article-title":"Neurological findings in incontinentia pigmenti; A review","volume":"55","author":"Meuwissen","year":"2012","journal-title":"European Journal of Medical Genetics"},{"key":"10.1016\/bs.vh.2024.03.001_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023101","article-title":"Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo","volume":"6","author":"Michelfelder","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/bs.vh.2024.03.001_bib70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/cr800409e","article-title":"Nonviral vectors for gene delivery","volume":"109","author":"Mintzer","year":"2009","journal-title":"Chemical Reviews"},{"key":"10.1016\/bs.vh.2024.03.001_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00952-17","article-title":"Zika virus persistently infects and is basolaterally released from primary human brain microvascular endothelial cells","volume":"8","author":"Mladinich","year":"2017","journal-title":"MBio"},{"key":"10.1016\/bs.vh.2024.03.001_bib72","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/nbt856","article-title":"Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors","volume":"21","author":"Muller","year":"2003","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.vh.2024.03.001_bib73","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/mt.2012.186","article-title":"Displaying high-affinity ligands on adeno-associated viral vectors enables tumor cell-specific and safe gene transfer","volume":"21","author":"Munch","year":"2013","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3013","article-title":"Gene therapy for Glut1-deficient mouse using an adeno-associated virus vector with the human intrinsic GLUT1 promoter","volume":"20","author":"Nakamura","year":"2018","journal-title":"The Journal of Gene Medicine"},{"key":"10.1016\/bs.vh.2024.03.001_bib75","article-title":"Intra-cisterna magna delivery of an AAV vector with the GLUT1 promoter in a pig recapitulates the physiological expression of SLC2A1","author":"Nakamura","year":"2020","journal-title":"Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib76","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2022.05.042","article-title":"Focused ultrasound\/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain","volume":"348","author":"Ogawa","year":"2022","journal-title":"Journal of Controlled Release: Official\u00a0Journal of the Controlled Release Society"},{"key":"10.1016\/bs.vh.2024.03.001_bib77","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ymthe.2017.09.006","article-title":"In vivo selection of a computationally designed SCHEMA AAV library yields a novel variant for infection of adult neural stem cells in the SVZ","volume":"26","author":"Ojala","year":"2018","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib78","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1128\/JVI.77.12.6995-7006.2003","article-title":"Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding","volume":"77","author":"Opie","year":"2003","journal-title":"Journal of Virology"},{"key":"10.1016\/bs.vh.2024.03.001_bib79","first-page":"581","article-title":"Design and development of polymers for gene delivery","volume":"4","author":"Pack","year":"2005","journal-title":"Nature Reviews:\u00a0Drug Discovery"},{"key":"10.1016\/bs.vh.2024.03.001_bib80","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2017.04.012","article-title":"Tick-borne encephalitis virus infects human brain microvascular endothelial cells without compromising blood-brain barrier integrity","volume":"507","author":"Palus","year":"2017","journal-title":"Virology"},{"key":"10.1016\/bs.vh.2024.03.001_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2020.602236","article-title":"Brain delivery of nanomedicines: Trojan Horse liposomes for plasmid DNA gene therapy of the brain","volume":"2","author":"Pardridge","year":"2020","journal-title":"Frontiers in Medical Technology"},{"key":"10.1016\/bs.vh.2024.03.001_bib82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1525-0016(03)00123-0","article-title":"In vitro selection of viral vectors with modified tropism: The adeno-associated virus display","volume":"8","author":"Perabo","year":"2003","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib83","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJMoa2211644","article-title":"Gene therapy with etranacogene dezaparvovec for hemophilia B","volume":"388","author":"Pipe","year":"2023","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.vh.2024.03.001_bib84","first-page":"133","article-title":"Emptying the stores: Lysosomal diseases and therapeutic strategies","volume":"17","author":"Platt","year":"2018","journal-title":"Nature Reviews:\u00a0Drug Discovery"},{"key":"10.1016\/bs.vh.2024.03.001_bib85","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jnc.15621","article-title":"A novel strategy for delivering Niemann-Pick type C2 proteins across the blood-brain barrier using the brain endothelial-specific AAV-BR1 virus","volume":"164","author":"Rasmussen","year":"2023","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.vh.2024.03.001_bib86","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1128\/JVI.00209-12","article-title":"The threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing","volume":"86","author":"Raupp","year":"2012","journal-title":"Journal of Virology"},{"key":"10.1016\/bs.vh.2024.03.001_bib87","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41592-020-0799-7","article-title":"Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types","volume":"17","author":"Ravindra Kumar","year":"2020","journal-title":"Nature Methods"},{"key":"10.1016\/bs.vh.2024.03.001_bib88","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-021-03098-6","article-title":"Interactions of lipids, lipoproteins, and apolipoproteins with the blood-brain barrier","volume":"38","author":"Rhea","year":"2021","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/bs.vh.2024.03.001_bib89","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41569-021-00517-4","article-title":"The quiescent endothelium: Signalling pathways regulating organ-specific endothelial normalcy","volume":"18","author":"Ricard","year":"2021","journal-title":"Nature Reviews Cardiology"},{"key":"10.1016\/bs.vh.2024.03.001_bib90","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1084\/jem.20110398","article-title":"TAK1 in brain endothelial cells mediates fever and lethargy","volume":"208","author":"Ridder","year":"2011","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/bs.vh.2024.03.001_bib91","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1084\/jem.20150165","article-title":"Brain endothelial TAK1 and NEMO safeguard the neurovascular unit","volume":"212","author":"Ridder","year":"2015","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/bs.vh.2024.03.001_bib92","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51276","article-title":"A genome-wide view of the de-differentiation of central nervous system endothelial cells in culture","volume":"9","author":"Sabbagh","year":"2020","journal-title":"Elife"},{"key":"10.1016\/bs.vh.2024.03.001_bib93","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1002\/j.1460-2075.1991.tb04964.x","article-title":"Targeted integration of adeno-associated virus (AAV) into human chromosome 19","volume":"10","author":"Samulski","year":"1991","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.vh.2024.03.001_bib94","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg6618","article-title":"Primate-conserved carbonic anhydrase IV and murine-restricted LY6C1 enable blood-brain barrier crossing by engineered viral vectors","volume":"9","author":"Shay","year":"2023","journal-title":"Science Advances"},{"key":"10.1016\/bs.vh.2024.03.001_bib95","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1038\/sj.mt.6300293","article-title":"Characterization of the relationship of AAV capsid domain swapping to liver transduction efficiency","volume":"15","author":"Shen","year":"2007","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib96","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1525-0016(03)00042-X","article-title":"RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism","volume":"7","author":"Shi","year":"2003","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib97","doi-asserted-by":"crossref","first-page":"10220","DOI":"10.1073\/pnas.1001673107","article-title":"A viral assembly factor promotes AAV2 capsid formation in the nucleolus","volume":"107","author":"Sonntag","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2024.03.001_bib98","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00335-011-9368-9","article-title":"Polymorphisms in Ly6 genes in Msq1 encoding susceptibility to mouse adenovirus type 1","volume":"23","author":"Stier","year":"2012","journal-title":"Mammalian Genome: Official Journal of the International Mammalian Genome Society"},{"key":"10.1016\/bs.vh.2024.03.001_bib99","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/bs.vh.2024.03.001_bib100","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1093\/brain\/awac243","article-title":"Gene therapy targeting the blood-brain barrier improves neurological symptoms in a model of genetic MCT8 deficiency","volume":"145","author":"Sundaram","year":"2022","journal-title":"Brain"},{"key":"10.1016\/bs.vh.2024.03.001_bib101","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14152","article-title":"Brain microvasculature defects and Glut1 deficiency syndrome averted by early repletion of the glucose transporter-1 protein","volume":"8","author":"Tang","year":"2017","journal-title":"Nature Communications"},{"key":"10.1016\/bs.vh.2024.03.001_bib102","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145789","article-title":"An early endothelial cell\u2013specific requirement for Glut1 is revealed in Glut1 deficiency syndrome model mice","volume":"6","author":"Tang","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/bs.vh.2024.03.001_bib103","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fnmol.2015.00036","article-title":"Systemic AAVrh10 provides higher transgene expression than AAV9 in the brain and the spinal cord of neonatal mice","volume":"8","author":"Tanguy","year":"2015","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/bs.vh.2024.03.001_bib104","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.cell.2016.11.013","article-title":"Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder","volume":"167","author":"T\u0103rlungeanu Dora","year":"2016","journal-title":"Cell"},{"key":"10.1016\/bs.vh.2024.03.001_bib105","first-page":"14","article-title":"\u201cEndothelial Antibody Factory\u201d at the blood brain barrier: Novel approach to therapy of neurodegenerative diseases","author":"Thinard","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.vh.2024.03.001_bib106","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00253-003-1321-8","article-title":"Non-viral gene therapy: Polycation-mediated DNA delivery","volume":"62","author":"Thomas","year":"2003","journal-title":"Applied Microbiology and Biotechnology"},{"key":"10.1016\/bs.vh.2024.03.001_bib107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2011.01.002","article-title":"Gene delivery by pullulan derivatives in brain capillary endothelial cells for protein secretion","volume":"151","author":"Thomsen","year":"2011","journal-title":"Journal of Controlled Release: Official\u00a0Journal of the Controlled Release Society"},{"key":"10.1016\/bs.vh.2024.03.001_bib108","article-title":"Hepatitis E virus infects brain microvascular endothelial cells, crosses the blood-brain barrier, and invades the central nervous system","volume":"119","author":"Tian","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2024.03.001_bib109","first-page":"2072","article-title":"A human parvovirus, adeno-associated virus, as a eucaryotic vector: Transient expression and encapsidation of the procaryotic gene for chloramphenicol acetyltransferase","volume":"4","author":"Tratschin","year":"1984","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/bs.vh.2024.03.001_bib110","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature25739","article-title":"A molecular atlas of cell types and zonation in the brain vasculature","volume":"554","author":"Vanlandewijck","year":"2018","journal-title":"Nature"},{"key":"10.1016\/bs.vh.2024.03.001_bib111","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/gt.2011.143","article-title":"Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors","volume":"19","author":"Varadi","year":"2012","journal-title":"Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib112","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1099\/vir.0.000103","article-title":"Differential permissivity of human cerebrovascular endothelial cells to enterovirus infection and specificities of serotype EV-A71 in crossing an in vitro model of the human blood\u2013brain barrier","volume":"96","author":"Volle","year":"2015","journal-title":"Journal of General Virology"},{"key":"10.1016\/bs.vh.2024.03.001_bib113","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/s41593-021-00926-1","article-title":"The SARS-CoV-2 main protease M(pro) causes microvascular brain pathology by cleaving NEMO in brain endothelial cells.","volume":"24","author":"Wenzel","year":"2021","journal-title":"Nature Neuroscience"},{"key":"10.1016\/bs.vh.2024.03.001_bib114","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/01.CIR.0000109697.68832.5D","article-title":"Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors","volume":"109","author":"White","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/bs.vh.2024.03.001_bib115","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ymthe.2005.11.013","article-title":"Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses","volume":"13","author":"Work","year":"2006","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib116","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/0271678X15608644","article-title":"Apicobasal polarity of brain endothelial cells","volume":"36","author":"Worzfeld","year":"2016","journal-title":"Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/bs.vh.2024.03.001_bib117","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","article-title":"Effect of genome size on AAV vector packaging","volume":"18","author":"Wu","year":"2010","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.vh.2024.03.001_bib118","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"Journal of Virology"},{"key":"10.1016\/bs.vh.2024.03.001_bib119","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1039\/D0NA00879F","article-title":"Trafficking of JC virus-like particles across the blood\u2013brain barrier","volume":"3","author":"Ye","year":"2021","journal-title":"Nanoscale Advances"},{"key":"10.1016\/bs.vh.2024.03.001_bib120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nature Reviews. Genetics"},{"key":"10.1016\/bs.vh.2024.03.001_bib121","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1074\/jbc.M116.755819","article-title":"Interferon-inducible LY6E protein promotes HIV-1 infection","volume":"292","author":"Yu","year":"2017","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.vh.2024.03.001_bib122","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm8011","article-title":"Blood-brain barrier\u2013penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy","volume":"8","author":"Zou","year":"2022","journal-title":"Science Advances"}],"container-title":["Vitamins and Hormones","Blood-Brain Barrier"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672924000244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672924000244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T08:52:39Z","timestamp":1753260759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672924000244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443194047"],"references-count":122,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2024.03.001","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}